PharmEng Reports Second Quarter Earnings for 2008

TORONTO, ONTARIO--(Marketwire - August 29, 2008) - PharmEng International Inc. (TSX VENTURE: PII), a full-service consulting and contract manufacturing company, today reported its results for the period ended June 30, 2008. Following on the transitional first quarter where for the first time in Company history, the revenue generated in the second quarter from the contract manufacturing division (operating as Keata Pharma Inc. "Keata") exceeded the revenue generated from the consulting division (operating as PharmEng Technology Inc. "PTI"), the Company continued the trend of manufacturing revenue exceeding consulting revenue in the second quarter.